IRIS
STEFANI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 59.069
AS - Asia 16.685
EU - Europa 6.189
SA - Sud America 1.213
AF - Africa 120
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 15
Totale 83.317
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 58.851
SG - Singapore 13.099
CN - Cina 1.290
BR - Brasile 1.016
IE - Irlanda 971
RU - Federazione Russa 937
IT - Italia 883
UA - Ucraina 824
HK - Hong Kong 822
DE - Germania 682
VN - Vietnam 591
FR - Francia 572
GB - Regno Unito 344
SE - Svezia 245
JP - Giappone 220
FI - Finlandia 202
PL - Polonia 171
KR - Corea 150
CA - Canada 116
NL - Olanda 114
IN - India 108
AR - Argentina 76
ID - Indonesia 68
MX - Messico 66
BD - Bangladesh 65
AT - Austria 48
IQ - Iraq 44
ZA - Sudafrica 44
ES - Italia 38
TR - Turchia 37
EC - Ecuador 28
BE - Belgio 27
CO - Colombia 26
PK - Pakistan 26
UZ - Uzbekistan 24
EU - Europa 23
VE - Venezuela 20
CZ - Repubblica Ceca 18
CL - Cile 17
MA - Marocco 17
SA - Arabia Saudita 16
PY - Paraguay 15
CH - Svizzera 14
EG - Egitto 14
KG - Kirghizistan 14
AU - Australia 13
PH - Filippine 13
KE - Kenya 12
AE - Emirati Arabi Uniti 11
IL - Israele 11
LT - Lituania 11
MY - Malesia 11
RO - Romania 11
AL - Albania 10
GR - Grecia 9
RS - Serbia 9
TW - Taiwan 9
BG - Bulgaria 8
PE - Perù 8
TN - Tunisia 8
AZ - Azerbaigian 7
JM - Giamaica 7
SK - Slovacchia (Repubblica Slovacca) 7
BO - Bolivia 6
IR - Iran 6
JO - Giordania 6
NP - Nepal 6
PT - Portogallo 6
DO - Repubblica Dominicana 5
GE - Georgia 5
HR - Croazia 5
LB - Libano 5
TH - Thailandia 5
DZ - Algeria 4
HN - Honduras 4
KZ - Kazakistan 4
NG - Nigeria 4
AO - Angola 3
BB - Barbados 3
BY - Bielorussia 3
DK - Danimarca 3
DM - Dominica 3
ET - Etiopia 3
LA - Repubblica Popolare Democratica del Laos 3
NI - Nicaragua 3
PA - Panama 3
PS - Palestinian Territory 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BW - Botswana 2
CR - Costa Rica 2
EE - Estonia 2
HU - Ungheria 2
MD - Moldavia 2
MT - Malta 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
Totale 83.295
Salva come PNG Salva come JPEG
Città #
Wilmington 15.477
Houston 14.759
Woodbridge 13.791
Fairfield 2.189
Singapore 1.979
Ashburn 1.248
Ann Arbor 1.097
San Jose 905
Seattle 842
Hong Kong 817
Jacksonville 746
Cambridge 742
Chandler 712
Dublin 650
Beijing 524
Medford 493
Dearborn 407
Santa Clara 323
The Dalles 295
Rome 281
Lawrence 229
Los Angeles 211
New York 211
Tokyo 197
Lauterbourg 187
Council Bluffs 171
Hanoi 163
Ho Chi Minh City 155
Buffalo 137
Moscow 137
San Diego 114
Kraków 110
Menlo Park 109
Munich 101
São Paulo 98
London 85
North Bergen 72
Helsinki 67
Dallas 66
Milan 59
Redondo Beach 57
Chicago 52
Brooklyn 48
Mülheim 48
Warsaw 47
Amsterdam 45
Phoenix 45
Atlanta 44
Nuremberg 43
Norwalk 42
Orem 41
Jakarta 40
Redwood City 39
Shanghai 39
Toronto 39
Montreal 38
Zhengzhou 37
Stockholm 35
Chennai 34
Johannesburg 32
Rio de Janeiro 32
Hefei 30
Boston 29
Da Nang 28
Denver 28
Seoul 28
Verona 28
Belo Horizonte 26
Durham 26
Brussels 25
Mexico City 25
Palo Alto 25
Boardman 24
Manchester 24
Kunming 22
Salt Lake City 22
Falls Church 21
Nanjing 21
St Louis 21
Elk Grove Village 20
Mountain View 20
Haiphong 19
University Park 19
Dhaka 17
Frankfurt am Main 16
Guangzhou 16
Guarulhos 16
Ninh Bình 16
Poplar 16
Salvador 16
Shenzhen 16
Tashkent 16
Biên Hòa 15
Brasília 15
Vienna 14
Detroit 13
Florence 13
San Francisco 13
Turku 13
Baghdad 12
Totale 62.617
Salva come PNG Salva come JPEG
Nome #
Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia 615
The pharmacological blockade of medial forebrain bundle induces an acute pathological synchronization of the cortico-subthalamic nucleus-globus pallidus pathway. 609
Strength and weaknesses of cerebrospinal fluid biomarkers in Alzheimer's disease and possible detection of overlaps with frailty process 607
Reasons driving treatment modification in Parkinson's disease: results from the cross-sectional phase of the REASON study. 598
Deep brain stimulation of CM/PF of thalamus could be the new elective target for tremor in advanced Parkinson's Disease? 597
Opioid-mediated modulation of calcium currents in striatal and pallidal neurons following reserpine treatment: focus on kappa response. 596
The impact of rotigotine on cardiovascular autonomic function in early Parkinson's disease 594
Tetrabenazine improves levodopa-induced peak-dose dyskinesias in patients with Parkinson's disease 591
Therapy for dyskinesias in Parkinson’s disease patients 587
Pathological gambling from dopamine agonist and deep brain stimulation of the nucleus tegmenti pedunculopontine 586
Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: molecular imaging with 123I-FP-CIT SPECT 585
Rasagiline effect on bladder disturbances in early mild Parkinson's disease patients 569
Subdyskinetic apomorphine responses in globus pallidus and subthalamus of parkinsonian patients: lack of clear evidence for the 'indirect pathway' 564
Posterior cortical atrophy with unilateral occipito-temporal degeneration 561
Motor and non-motor effects of PPN-DBS in PD patients: insights from intra-operative electrophysiology 549
Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects 547
Re: Stereotactic microdialysis of the basal ganglia in Parkinson's disease 546
The effect of deep brain stimulation on the frontal N30 component of somatosensory evoked potentials in advanced Parkinson's disease patients 541
Successful subthalamic stimulation, but levodopa-induced dystonia, in a genetic Parkinson's disease 540
Reduced GABA Content in the Motor Thalamus during effective deep brain stimulation of the subthalamic nucleus 536
Rasagiline effect on bladder disturbances in early mild Parkinson's disease patients 523
Neuroacanthocytosis associated with a defect of the 4.1R membrane protein 518
Multi-target strategy for Parkinsonian patients: the role of deep brain stimulation in the centromedian-parafascicularis complex. 518
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis. 505
Effects of deep brain stimulation of the peduncolopontine area on working memory tasks in patients with Parkinson's disease 505
Spontaneous sleep modulates the firing pattern of Parkinsonian subthalamic nucleus 503
Intensity-dependent facial emotion recognition and cognitive functions in Parkinson's disease 500
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis 492
Clinical and genetic study of a large SPG4 Italian family 491
Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a natural population of cognitive intact Parkinson's Disease patients. 490
Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease 489
Do CSF levels of t-Tau, p-Tau and beta(1-42) amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A I-123-FP-CIT study in the early stages of the disease 488
Autonomic Function Tests and MIBG in Parkinson's Disease: Correlation to Disease Duration and Motor Symptoms 483
CSF biomarkers, impairment of cerebral hemodynamics and degree of cognitive decline in Alzheimer's and mixed dementia 482
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. I. Modulation of corticostriatal synaptic transmission 479
The clinical efficacy of L-DOPA and STN-DBS share a common marker: reduced GABA content in the motor thalamus. 479
Homovanillic acid in CSF of mild stage Parkinson's disease patients correlates with motor impairment 478
Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration 477
Sad and happy facial emotion recognition impairment in progressive supranuclear palsy in comparison with Parkinson's disease 470
Selective vulnerability of pallidal neurons in the early phases of manganese intoxication 469
Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease 469
Tetrabenazine improves levodopa-induced peak-dose dyskinesias in patients with Parkinson's disease 468
Acute inactivation of the medial forebrain bundle imposes oscillations in the SNr: a challenge for the 6-OHDA model? 467
Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease 466
Microdialysis in Parkinsonian patient basal ganglia: acute apomorphine-induced clinical and electrophysiological effects not paralleled by changes in the release of neuroactive amino acids 466
Cardiac sympathetic denervation is not related to nigrostriatal degeneration in Parkinson's disease 465
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents 462
Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson’s disease patients with chronic pain 462
Differential post-translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid. 460
Acute nigro-striatal blockade alters cortico-striatal encoding: An in vivo electrophysiological study 459
Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature 453
The early course of affective and cognitive symptoms in de novo patients with Parkinson's disease 452
A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices 450
Serotonin impairment in CSF of PD patients, without an apparent clinical counterpart 447
Distinct roles of cortical and pallidal β and γ frequencies in hemiparkinsonian and dyskinetic rats 447
Adherence to anti-Parkinson drug therapy in the "rEASON" sample of Italian patients with Parkinson's disease: The linguistic validation of the Italian version of the "morisky Medical Adherence scale-8 items" 446
Activation of metabotropic glutamate receptors inhibits calcium currents and GABA-mediated synaptic potentials in striatal neurons 445
Subthalamic stimulation and levodopa modulate cortical reactivity in Parkinson's patients 445
Deep brain stimulation of pedunculopontine tegmental nucleus: role in sleep modulation in advanced Parkinson disease patients: one-year follow-up. 443
The clinical efficacy of L-DOPA and STN-DBS share a common marker: reduced GABA content in the motor thalamus 441
Neurotensin effects on N-type calcium currents among rat pallidal neurons: an electrophysiological and immunohistochemical study. 441
Bilateral GPi DBS is useful to reduce abnormal involuntary movements in advanced Parkinson's disease patients, but its action is related to modality and site of stimulation 438
Altered profile and D2-dopamine receptor modulation of high voltage-activated calcium current in striatal medium spiny neurons from animal models of Parkinson's disease. 437
CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD 436
Differential post-translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid. 435
Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer’s disease 434
Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations 433
Pedunculopontine nucleus stimulation influences REM sleep in Parkinson's disease 432
Stimulation of the subthalamic nucleus compared with the globus pallidus internus in patients with Parkinson disease 428
Electrophysiology of dopamine D-1 receptors in the basal ganglia: old facts and new perspectives 427
Deep brain stimulation of both subthalamic nucleus and internal globus pallidus restores intracortical inhibition in Parkinson's disease paralleling apomorphine effects: a paired magnetic stimulation study 427
CSF biomarker variability in the Alzheimer's Association quality control program 424
Alexithymia is a non-motor symptom of Parkinson disease 423
Thalamic ¹²³I FP-CIT uptake in a patient with clinical diagnosis of Parkinson's disease and depression 423
Association analysis between Alzheimer's disease and the Nicastrin gene polymorphisms 423
Subthalamic stimulation activates internal pallidus: evidence from cGMP microdialysis in PD patients 422
Vulnerability of medium spiny striatal neurons to glutamate: role of Na+/K+ ATPase 422
Outward potassium currents activated by depolarization in rat globus pallidus 422
Microdialysis in Parkinsonian patient basal ganglia: acute apomorphine-induced clinical and electrophysiological effects not paralleled by changes in the release of neuroactive amino acids 419
In vivo electrophysiology of dopamine-denervated striatum: focus on the nitric oxide/cGMP signaling pathway. 415
Pramipexole in comparison to l-dopa: a neuropsychological study 412
Effective treatment of restless legs syndrome by safinamide in Parkinson's disease patients 410
Theta Burst Stimulation Modulates Cerebellar-Cortical Connectivity in Patients with Progressive Supranuclear Palsy 409
Catecholamine-based treatment in AD patients: expectations and delusions 408
D2-mediated modulation of N-type calcium currents in rat globus pallidus neurons following dopamine denervation 407
The modulation of dopamine receptors in rat striatum 407
Rotigotine effect on sleep in a de novo Parkinson's Disease patient affected by periodic limb movement disorder 407
Different patterns of cardiac sympathetic denervation in tremor-type compared to akinetic-rigid-type Parkinson's disease: molecular imaging with ¹²³I-MIBG. 406
Basic research in substantia nigra and ventral tegmental area: clinical implications 406
Deep brain stimulation of the pedunculopontine tegmentum and subthalamic nucleus: effects on gait in Parkinson's disease 402
The modulation of calcium currents by the activation of mGluRs. Functional implications 402
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers 401
Hemodynamic changes in Alzheimer's disease: A leading role behind the courtain? Commentary on "CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease" by Lista et al 400
CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment 399
Deep brain stimulation in Parkinson's disease patients: biochemical evidence 398
Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. 394
Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations.(Reply from the authors) 393
Cardiac rhabdomyosarcoma: a clinicopathologic and electron microscopy study 390
Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study. 390
Psychiatric profile of motor subtypes of de novo drug-naïve Parkinson's disease patients 390
Totale 47.062
Salva come PNG Salva come JPEG
Categoria #
all - tutte 191.463
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 191.463
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021804 0 0 0 0 0 0 0 0 0 204 501 99
2021/20222.802 58 342 137 125 87 152 586 143 134 142 229 667
2022/20232.175 271 160 78 217 166 592 240 115 167 6 118 45
2023/2024855 90 33 63 18 85 143 36 144 22 53 14 154
2024/202515.378 171 1.254 584 330 113 471 464 347 637 521 6.021 4.465
2025/20269.260 810 380 1.171 918 879 345 1.289 1.442 1.217 809 0 0
Totale 84.325